BRCA1/MAD2L1 Deficiency Disrupts the Spindle Assembly Checkpoint to Confer Vinorelbine Resistance in Mesothelioma
- 1 February 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 20 (2), 379-388
- https://doi.org/10.1158/1535-7163.mct-20-0363
Abstract
Mesothelioma is a universally lethal cancer lacking effective therapy. The spindle poison vinorelbine exhibits clinical activity in relapsed setting, and in preclinical models requires BRCA1 to initiate apoptosis. However, the mechanisms underlying this regulation and the clinical implications have not been explored. Here we show that BRCA1 silencing abrogated vinorelbine-induced cell cycle arrest, recruitment of BUBR1 to kinetochores, and apoptosis. BRCA1 silencing led to co-depletion of MAD2L1 at the mRNA and protein levels consistent with its status as a transcriptional target of BRCA1. Silencing of MAD2L1 phenocopied BRCA1, and was sufficient to confer resistance to vinorelbine. This was recapitulated in cell lines selected for resistance to vinorelbine, which acquired loss of both BRCA1 and MAD2L1 expression. Following ex-vivo vinorelbine in 20 primary tumour explants, apoptotic response rate was 59% in BRCA1/MAD2L1 positive explants compared with 0% in BRCA1/MAD2L1 negative explants. In 48 patients BRCA1 and/or MAD2L1 loss of expression was not prognostic, however in a subset of patients treated with vinorelbine, survival was shorter for patients lacking BRCA1/MAD2L1 expression compared with double positive patients (5.9 versus 36.7 months, p=0.03). Our data implicates BRCA1/MAD2L1 loss as a putative predictive marker of resistance to vinorelbine in mesothelioma, and warrants prospective clinical evaluation.Keywords
Other Versions
Funding Information
- June Hancock Mesothelioma Research Fund (JH/09/2011)
This publication has 27 references indexed in Scilit:
- BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signalingOncogene, 2013
- BRCA1 is an essential mediator of vinorelbine‐induced apoptosis in mesotheliomaThe Journal of Pathology, 2011
- Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysisNucleic Acids Research, 2011
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesotheliomaNature Genetics, 2011
- Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialThe Lancet, 2008
- The BRCA1/BARD1 Heterodimer Modulates Ran-Dependent Mitotic Spindle AssemblyCell, 2006
- BRCA1 Downregulation Leads to Premature Inactivation of Spindle Checkpoint and Confers Paclitaxel ResistanceCell Cycle, 2006
- BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agentsOncogene, 2001
- Prognostic significance of DNA aneuploidy in diffuse malignant mesotheliomaCytometry, 1995